Rhinomed Investor Briefing – 17 June
Rhinomed Limited (ASX: RNO) Webcast Replay
Rhinomed Limited (ASX.RNO) is a Melbourne based ASX listed airway technology company that has developed a simple and innovative nasal stent to improve air flow to the lungs and deliver therapeutic agents.
As a part of our ‘Meet the CEOs’ series, CEO Michael Johnson provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 17th June 2020 at 12pm (AEST).